BRIEF published on 04/09/2024 at 18:05, 1 year 7 months ago Intraprise Solutions and Level1Analytics Join Forces, Providing Advanced Valuation Software to the Banking Industry Banking Industry Intraprise Solutions Level1Analytics Valuation Software Financial Modeling
BRIEF published on 04/09/2024 at 18:05, 1 year 7 months ago Intraprise Solutions et Level1Analytics unissent leurs forces pour fournir un logiciel d'évaluation avancé au secteur bancaire L'industrie Banquaire Solutions Intra-entreprises Analyse De Niveau 1 Logiciel D'évaluation Modélisation Financière
PRESS RELEASE published on 04/09/2024 at 18:00, 1 year 7 months ago Intraprise Solutions and Level1Analytics Join Forces, Providing Advanced Valuation Software to the Banking Industry Intraprise Solutions, Inc. and Level1Analytics LLC merge to offer Level1Analytics®, a valuation and stress testing SaaS solution for the banking industry Banking Industry Intraprise Solutions Level1Analytics Financial Modeling Valuation Platform
Published on 12/05/2025 at 02:35, 4 hours 2 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 37 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 32 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 37 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 6 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 46 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 11 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 22 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 26 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 22 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 37 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 37 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 52 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 52 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
